Tesamorelin
A growth hormone-releasing peptide at SSK Longevity in Newport Beach, California, prescribed for body composition support, visceral fat reduction, and metabolic optimization.
A Growth Hormone-Releasing Peptide With a Visceral Fat Focus
Tesamorelin is a stabilized analog of GHRH (growth hormone-releasing hormone), FDA-approved as the branded medication Egrifta to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Compared to other GHRH analogs, it is particularly notable for its effect on visceral adipose tissue. It is sometimes paired with Ipamorelin; learn more in our Ipamorelin Guide.
At SSK Longevity in Newport Beach, tesamorelin may be prescribed off-label or in compounded form by Dr. Sean Kelishadi, MD FACS, under Sherry Kelishadi, Pharm.D.'s direct pharmacy oversight for Newport Beach, Costa Mesa, Irvine, and broader Orange County patients.
How Tesamorelin Works
Tesamorelin activates the GHRH receptor on the pituitary gland, increasing the body's own growth hormone pulses and IGF-1. Its stabilized structure gives it a longer effect than natural GHRH, and its documented impact on visceral fat sets it apart from other growth hormone-releasing peptides.
Stabilized GHRH Analog
Tesamorelin is a structurally stabilized analog of growth hormone-releasing hormone (GHRH), designed to resist rapid breakdown and signal the pituitary to release the body's own growth hormone.
Natural GH and IGF-1 Release
By activating the GHRH receptor, tesamorelin increases natural growth hormone pulses and IGF-1 levels, rather than introducing growth hormone directly.
Visceral Fat Targeting
In clinical trials, tesamorelin reduced visceral adipose tissue, the deep abdominal fat linked to metabolic and cardiovascular risk. This is the basis of its FDA approval as Egrifta.
Tesamorelin, Compounded for Visceral Fat Outcomes
Every Tesamorelin protocol at SSK Longevity Newport Beach is compounded under Sherry Kelishadi, Pharm.D.'s direct review. Dose ratios, injection timing, and complementary peptide layering are evaluated individually for each patient before dispensing.
Newport Beach, Costa Mesa, Irvine, and Orange County patients receive a Tesamorelin protocol calibrated to their physiology, body composition goals, and longevity priorities.
Individual results are not guaranteed and may vary from person to person.
- Personalized lab review and metabolic assessment
- Compounded under Pharm.D. supervision in Newport Beach
- Individualized dose protocols tailored to your physiology
- Drug interaction review before anything is dispensed
- Direct physician access throughout treatment
- Coordinated care with complementary protocols when appropriate
Peptides Layered With Or Compared To Tesamorelin
Patients on tesamorelin in Newport Beach often layer or transition between growth peptides and metabolic peptides for body composition, recovery, and longevity goals.
Peptide Therapy Stacked With Tesamorelin
Tesamorelin is rarely the whole protocol. SSK Longevity Newport Beach patients commonly layer it with weight management, metabolic, or hormonal protocols. Sherry Kelishadi, Pharm.D. coordinates every combined protocol individually before dispensing.
CJC-1295
A GHRH analog at SSK Longevity. CJC-1295 differs from tesamorelin in release profile and clinical emphasis.
Learn More →MOTS-c
Mitochondrial-derived peptide layered with growth peptides for cellular energy, metabolic regulation, and longevity depth.
Learn More →Epithalon
Telomere-supportive peptide commonly cycled alongside growth peptides in longevity protocols at SSK Longevity.
Learn More →Tesamorelin Benefits at SSK Longevity in Newport Beach, CA
Tesamorelin at SSK Longevity in Newport Beach is used for visceral fat reduction, body composition support, and metabolic optimization. Tesamorelin is FDA-approved as Egrifta for a specific indication and may be prescribed off-label in compounded form under Pharm.D. supervision for patients across Newport Beach, Costa Mesa, Irvine, Laguna Beach, Huntington Beach, and Orange County. Below are the outcomes tesamorelin patients commonly report.
Visceral Adipose Tissue Reduction
Tesamorelin's most distinctive clinical effect is on visceral fat — the deep abdominal fat associated with metabolic dysfunction and cardiovascular risk.
Body Composition Support
Natural growth hormone release supports lean mass preservation alongside fat reduction during structured protocol cycles.
Metabolic Markers
Improvements in lipid panels and inflammatory markers are commonly observed alongside body composition changes.
Recovery & Sleep Quality
Patients commonly report deeper sleep and improved recovery — driven by improved nighttime growth hormone release.
Skin Quality & Collagen
Growth hormone supports collagen synthesis and skin quality, complementary to aesthetic protocols at SSK.
Stamina & Energy
Patients describe steadier energy and improved exercise tolerance over the course of a 3-6 month protocol cycle.
Is Tesamorelin Right For You?
Tesamorelin at SSK Longevity Newport Beach is appropriate for adults seeking medically supervised peptide therapy with physician oversight, lab-driven protocol design, and Pharm.D.-supervised compounding. Patients pursuing this protocol typically fit one or more of the profiles below.
Conditions Treated Alongside Tesamorelin in Newport Beach
Aging Skin
Growth peptide therapy supports collagen synthesis, skin quality, and cellular recovery commonly addressed in aging skin protocols.
→
Poor Muscle Recovery
Lean mass preservation, training recovery, and tissue repair are primary indications for growth peptide therapy.
→
Fatigue & Low Energy
Hormone-related fatigue and recovery deficits frequently improve alongside growth peptide therapy.
→
Hormonal Imbalance
Hormonal optimization commonly pairs with growth peptide therapy for comprehensive longevity care.
→How Tesamorelin Cycles Are Built at SSK Longevity
Comprehensive Consultation
Lab review, medical history, and body composition assessment with the SSK Longevity team in Newport Beach.
Personalized Protocol
Tesamorelin dosing, injection timing, protocol length, and whether any pairing is appropriate, calibrated to your physiology and goals.
Pharmacist Compounding
Sherry Kelishadi, Pharm.D. oversees every compounded Tesamorelin vial dispensed by SSK Longevity.
Ongoing Clinical Oversight
Scheduled follow-ups, lab rechecks, and dose adjustments calibrated to your response over time.
Tesamorelin Safety, Off-Label Status, and Monitoring
Tesamorelin therapy under proper medical supervision has a well-characterized safety profile, but real considerations deserve direct discussion before any Newport Beach patient begins a protocol.
-
—
FDA-approved for a specific indication Tesamorelin is FDA-approved as Egrifta to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Other uses are off-label, and compounded forms are not FDA-approved. Discussed openly with every patient.
-
—
IGF-1 elevation requires close monitoring Tesamorelin produces stronger IGF-1 elevation than CJC-1295. Pre-protocol baseline and follow-up testing are essential. Levels are kept in physiologic range through dose adjustment.
-
—
Glucose monitoring during cycles Sustained GH elevation can affect insulin sensitivity, particularly with the deeper effect of Tesamorelin. Glucose and HbA1c are monitored throughout the cycle.
-
—
Mild injection-site reactions Localized redness or irritation are most common. Typically self-limited and improve with rotation of injection sites.
-
—
Contraindicated in active malignancy Growth hormone elevation is generally avoided in patients with active or recent malignancy. Cancer history is screened during initial evaluation.
-
—
Cycling is critical, not continuous use Tesamorelin protocols are particularly important to cycle. Continuous long-term use is reserved for specific clinical situations under careful monitoring.
What patients actually say.
"After years of stubborn central fat that wouldn't move, this protocol finally worked. SSK calibrated everything to my labs."
"My recovery improved noticeably and my body composition shifted in a way Tirzepatide alone hadn't given me."
"Sherry's involvement made the difference. I've been to clinics that just refill peptides. SSK is genuinely a pharmacy with physicians."
From Our Founders
Tesamorelin's effect on visceral adipose tissue is its distinguishing clinical feature, and it's the reason it carries an FDA approval. For patients whose body composition concerns center on stubborn central fat, tesamorelin is often a better fit than other growth peptides.
The pharmacology of tesamorelin matters. It's a stabilized GHRH with specific clinical activity, and dosing it accurately, and deciding whether anything should be paired with it, requires real pharmacy involvement. That's exactly what we provide at SSK Longevity.
Why Tesamorelin Patients Choose SSK Longevity
Tesamorelin FAQ for Newport Beach & Orange County
How is Tesamorelin different from CJC-1295?
Both are GHRH analogs, but tesamorelin has documented clinical activity on visceral adipose tissue and an FDA approval for a specific indication. CJC-1295 tends to be more general-purpose; tesamorelin is favored when body composition and visceral fat are primary concerns.
Is Tesamorelin FDA-approved?
Yes, for a specific use. Tesamorelin is FDA-approved as Egrifta to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. At SSK Longevity, it may be prescribed off-label or in compounded form under physician supervision. Compounded formulations are not FDA-approved.
Can Tesamorelin be combined with Ipamorelin?
Yes. Tesamorelin is sometimes paired with Ipamorelin, a GHRP that stimulates growth hormone release through a different receptor. Whether a pairing is appropriate depends on your goals, labs, and history, and is decided with your physician.
How is Tesamorelin layered with weight loss medications?
Many SSK Longevity patients combine tesamorelin with Semaglutide or Tirzepatide for visceral fat reduction and lean mass preservation during weight loss. Layering is always reviewed by Sherry Kelishadi, Pharm.D. before dispensing.
What labs are monitored during treatment?
IGF-1 is the primary marker monitored. Comprehensive metabolic and lipid panels may be checked periodically depending on your individualized protocol.
How is Tesamorelin injected?
Tesamorelin is administered as a daily subcutaneous injection. Timing is set as part of your individualized protocol. Most patients follow a 3-6 month protocol cycle, individualized based on goals, response, and lab markers.
What are the most common side effects?
Most patients tolerate the protocol well. Possible side effects include injection-site irritation, mild flushing, and occasional water retention during early cycles.
Where is SSK Longevity located?
SSK Longevity is in Newport Beach, California, at 500 Superior Avenue, Suite 340 — serving patients across Orange County including Costa Mesa, Irvine, Huntington Beach, and Laguna Beach.
Treatments Stacked With Visceral Fat Protocols at SSK Longevity
Peptide Therapy for Longevity
The broader peptide therapy program of which Tesamorelin is a key component.
→
Metabolic Performance Optimization
Metabolic optimization commonly layered with Tesamorelin for visceral fat reduction and metabolic flexibility.
→
Hormone Replacement Therapy
Hormonal optimization commonly paired with growth peptide therapy for comprehensive longevity care.
→
Athletic Recovery Therapy
Athletic recovery protocols commonly layer growth peptides with other recovery support.
→Tesamorelin is FDA-approved as a branded medication (Egrifta) for a specific indication. At SSK Longevity, tesamorelin may be prescribed off-label or in compounded form under physician supervision. Compounded formulations are not FDA-approved. The information on this page is for educational purposes only and does not constitute medical advice. Treatment requires physician evaluation, comprehensive laboratory testing, and ongoing clinical oversight. Compounded peptide therapy is generally an out-of-pocket service and is not typically covered by insurance. Payment options and financing are available. Individual results are not guaranteed and may vary from person to person. All treatments are administered under the supervision of a licensed physician.